Strides Pharma Science Ltd Share Price (STAR)
Check the latest share price of Strides Pharma Science Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Strides Pharma Science Ltd Stock Performance
Get live Strides Pharma Science Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹840Day's Price Range₹889.852 Week's Low
52 Week's High
₹513.0552-Week Price Range₹1,675
| Returns % | |
| 1 Month Return | + 33.27 % |
| 3 Month Return | + 50.01 % |
| 1 Year Return | -9.83 % |
| 3 Year Return | + 184.39 % |
| 5 Year Return | + 120.5 % |
| Market Stats | |
| Previous Close | ₹854.10 |
| Open | ₹845.00 |
| Volume | 7.38L |
| Upper Circuit | ₹1,024.90 |
| Lower Circuit | ₹683.30 |
Strides Pharma Science Ltd Fundamentals & Key Indicators
Check Strides Pharma Science Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹8,132.90 Cr
Return on Equity (ROE)
1.87
PE Ratio (TTM)
34.95
Return on capital employed (ROCE)
4.68
Industry PE ratio
57.39
Beta (LTM)
1.11
P/B Ratio
2.02
Dividend Yield
0.32
PEG Ratio
1.22
Quarterly Earnings Growth YOY
720.11
EPS (TTM)
-4.49599698514042
Sector
Pharmaceuticals
Book Value
101.35
Technical Analysis
Bullish
View Technical Analysis
How to invest in Strides Pharma Science Ltd?
Investing in Strides Pharma Science Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Strides Pharma Science Ltd or STAR on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Strides Pharma Science Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Strides Pharma Science Ltd with just a few clicks!
Strides Pharma Science Ltd Stock's Interest Amongst Investors
Strides Pharma Science Ltd Valuation
Track how Strides Pharma Science Ltd P/E has moved over time to understand its valuation trends.
Strides Pharma Science Ltd in the last 5 years
Lowest (-409.06x)
July 5, 2021
Today (34.95x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (6306.63x)
September 27, 2024
Today’s Price to Earnings Ratio: 34.95x
Strides Pharma Science Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Strides Pharma Science Ltd.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Strides Pharma Science Ltd. Average target price of ₹1013.5
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Share Price Target
Get share price movements and forecasts by analysts on Strides Pharma Science Ltd.
Strides Pharma Science Ltd price forecast by 2 analysts
Upside of14.85%
High
₹1090
Target
₹1013.50
Low
₹937
Strides Pharma Science Ltd target price ₹1013.5, a slight upside of 14.85% compared to current price of ₹882.45. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Strides Pharma Science Ltd revenue growth forecast
Expected growth rate Q1, FY2027:42.89%
Forecast
Actual
Including amortisation and stock based compensations
Strides Pharma Science Ltd EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Financial Results
Get the annual and quarterly financial summary of Strides Pharma Science Ltd, including revenue, profit, loss and more.
Indices Featuring Strides Pharma Science Ltd Stock
Check stock indices that include Strides Pharma Science Ltd.
Strides Pharma Science Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Strides Pharma Science Ltd.
Strides Pharma Science Ltd Earnings Results
Strides Pharma Science Ltd’s net profit jumped 352.09% since last year same period to ₹82.19Cr in the Q4 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated -6.55% fall in its net profits since last 3-months.
Read More about Earnings ResultsStrides Pharma Science Ltd Dividends May,2024
In the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.45%.
Read More about Dividends
Strides Pharma Science Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Strides Pharma Science Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 28.3% | 0.00 | |
| Foreign Institutions | 28.32% | 0.00 | |
| Mutual Funds | 8.89% | 0.00 | |
| Retail Investors | 29.65% | 0.00 | |
| Others | 4.84% | 0.00 |
Strides Pharma Science Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Strides Pharma Science Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 8,132.90 | 24.1% | 0.66 | -95 | 4,051 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Strides Pharma Science Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Strides Pharma Science Ltd.
Strides Pharma Shows Strong Bullish Momentum - 11 Jun, 2025
Strides Pharma is in a strong uptrend, breaking out above Rs 760 with significant volume. The stock is above key moving averages, indicating bullish sentiment. Expected upside is Rs 875-930, with support at Rs 790-775.Strides Pharma Hits New High After Consolidation - 05 Jun, 2025
Strides Pharma Science Ltd has broken out from a 7-month consolidation phase, reaching a fresh 52-week high. The stock has rallied over 10% in a week, with experts suggesting a target of Rs 960 for short-term traders.Strides Pharma Science Shows Strong Bullish Momentum - 30 May, 2025
Strides Pharma Science shares have broken past key resistance levels, supported by strong volume and positive technical indicators. Axis Securities recommends a Buy with potential upside of 18% in the short term.Strides Pharma Targets $400 Million US Sales by FY28 - 23 May, 2025
Strides Pharma Science Ltd remains optimistic about its growth in the US market, maintaining a sales target of $400 million for FY28, supported by niche products generating $5-7 million each.Strides Pharma Reports Strong Q4 Earnings Growth - 22 May, 2025
Strides Pharma Science's Q4 net profit surged fivefold to Rs 113 crore, with revenue rising 17% YoY to Rs 1,190.4 crore, driven by robust US sales and improved margins. The company also announced a dividend of Rs 4 per share for FY25.Analysts Recommend Strides Pharma for Short-term Gains - 19 May, 2025
Analysts have identified Strides Pharma as a buy for the short term, with a target price of Rs 754, suggesting a potential upside of 14% from the current price of Rs 661.7.
Insights on Strides Pharma Science Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 26.82% to 28.30% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, STAR stock has moved up by 11.1%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.16K Cr → 1.20K Cr (in ₹), with an average increase of 3.8% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 27.77% to 29.65% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 55.1%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 10.86% to 8.89% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 28.48% to 28.32% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 87.95 Cr → 82.19 Cr (in ₹), with an average decrease of 6.6% per quarter
About Strides Pharma Science Ltd
Revenue: ₹1,190.39Cr as on March 2025 (Q4 FY25)
Net Profit: ₹85.62Cr as on March 2025 (Q4 FY25)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
| Organisation | Strides Pharma Science Ltd |
| Headquarters | Bangaluru |
| Industry | Pharmaceuticals |
| CEO | Arun Kumar |
| E-voting on shares | Click here to vote |
Mutual Funds that own Strides Pharma Science Ltd
Check out the Mutual Funds with significant holdings in Strides Pharma Science Ltd.
FAQs
What is Strides Pharma Science Ltd share price today?
Strides Pharma Science Ltd share price today stands at ₹882.45, Open: ₹845, Previous Close: ₹854.1, High: ₹889.8, Low: ₹840, 52 Week High: ₹1675, 52 Week Low: ₹513.05.
What is today's traded volume of Strides Pharma Science Ltd?
Today's traded volume of Strides Pharma Science Ltd is 7.38L. Which means that 7.38L shares of Strides Pharma Science Ltd were bought and sold on the stock market during today's trading session.
What is Strides Pharma Science Ltd's market cap today?
Today's market capitalisation of Strides Pharma Science Ltd is ₹8,132.90 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Strides Pharma Science Ltd?
Strides Pharma Science Ltd’s 52 week high is ₹1675 and 52 week low is ₹513.05. The current share price of Strides Pharma Science Ltd is ₹882.45, which is -47.32% down from its 52 week high and 72.00% up from its 52 week low.